Log In
BCIQ
Print this Print this
 

24sure

  Manage Alerts
Collapse Summary General Information
Company Illumina Inc.
DescriptionDiagnostic that screens for 24 chromosome aneuploidy
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDiagnose 24 chromosome aneuploidy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/24/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today